keyword
https://read.qxmd.com/read/38634480/increasing-severity-of-medical-outcomes-and-associated-substances-in-cases-reported-to-united-states-poison-centers
#21
JOURNAL ARTICLE
Rita Farah, Ryan J Cole, Christopher P Holstege
INTRODUCTION: Poison centers provide free expert recommendations on the treatment of a wide variety of toxicological emergencies. Prior studies have called attention to the increasing complexity of cases reported to poison centers. We aimed first, to evaluate the trends in medical outcome severity, over a 15-year period in both the adult and pediatric populations. Second, we described the most frequently reported substances associated with major effect or death. METHODS: This is a retrospective review of exposures reported to the National Poison Data System from 1 January 2007 through 31 December 2021...
April 18, 2024: Clinical Toxicology
https://read.qxmd.com/read/38634432/assessing-the-clinical-efficacy-of-low-volume-therapeutic-plasma-exchange-in-achieving-recovery-from-acute-liver-failure-induced-by-yellow-phosphorous-poisoning
#22
JOURNAL ARTICLE
Ancy Ninan, Ganesh Mohan, Vishal Shanbhag, Deepika Chenna, Shamee Shastry, Shwethapriya Rao
BACKGROUND: Acute liver failure (ALF) following yellow phosphorous (YP) ingestion is similar to acetaminophen-induced ALF and it has become a public concern in our region. This study assessed low volume therapeutic plasma exchange (LV-TPE) efficacy in improving the transplant free survival in YP poisoning. METHODS: Adult patients with toxicology reports of YP and ALF requiring critical care were included in the study. LV-TPE was planned for three consecutive days and three more if required...
June 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/38634393/effectiveness-of-antidepressants-in-combination-with-psychotherapy
#23
JOURNAL ARTICLE
Farrokh Alemi, Tulay G Soylu, Mary Cannon, Conor McCandless
BACKGROUND: Consensus-guidelines for prescribing antidepressants recommend that clinicians should be vigilant to match antidepressants to patient's medical history but provide no specific advice on which antidepressant is best for a given medical history. AIMS OF THE STUDY: For patients with major depression who are in psychotherapy, this study provides an empirically derived guideline for prescribing antidepressant medications that fit patients' medical history...
March 1, 2024: Journal of Mental Health Policy and Economics
https://read.qxmd.com/read/38634106/genome-and-clonal-hematopoiesis-stability-contrasts-with-immune-cfdna-mitochondrial-and-telomere-length-changes-during-short-duration-spaceflight
#24
JOURNAL ARTICLE
J Sebastian Garcia-Medina, Karolina Sienkiewicz, S Anand Narayanan, Eliah G Overbey, Kirill Grigorev, Krista A Ryon, Marissa Burke, Jacqueline Proszynski, Braden Tierney, Caleb M Schmidt, Nuria Mencia-Trinchant, Remi Klotz, Veronica Ortiz, Jonathan Foox, Christopher Chin, Deena Najjar, Irina Matei, Irenaeus Chan, Carlos Cruchaga, Ashley Kleinman, JangKeun Kim, Alexander Lucaci, Conor Loy, Omary Mzava, Iwijn De Vlaminck, Anvita Singaraju, Lynn E Taylor, Julian C Schmidt, Michael A Schmidt, Kelly Blease, Juan Moreno, Andrew Boddicker, Junhua Zhao, Bryan Lajoie, Andrew Altomare, Semyon Kruglyak, Shawn Levy, Min Yu, Duane C Hassane, Susan M Bailey, Kelly Bolton, Jaime Mateus, Christopher E Mason
BACKGROUND: The Inspiration4 (I4) mission, the first all-civilian orbital flight mission, investigated the physiological effects of short-duration spaceflight through a multi-omic approach. Despite advances, there remains much to learn about human adaptation to spaceflight's unique challenges, including microgravity, immune system perturbations, and radiation exposure. METHODS: To provide a detailed genetics analysis of the mission, we collected dried blood spots pre-, during, and post-flight for DNA extraction...
March 2024: Precision Clinical Medicine
https://read.qxmd.com/read/38634057/comparative-efficacy-and-safety-of-targeted-therapy-and-immunotherapy-for-her2-positive-breast-cancer-a-systematic-review-and-network-meta-analyses
#25
Suyu Gu, Yuting Liu, Yufan Huang, Wenzheng Lin, Ke Li
BACKGROUND: In recent years, novel therapies targeting specific molecular pathways and immunotherapies have exhibited promising outcomes for treating human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Our work aimed to assess the effectiveness and safety of these emerging treatment regimens for this disease. MATERIAL AND METHODS: We systematically searched databases including PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials their inception to August 2023 to identify relevant randomized controlled trials (RCTs)...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38634054/analysis-of-the-treatment-and-prognosis-of-266-cases-of-extranodal-natural-killer-t-cell-lymphoma-nasal-type-in-a-single-medical-center
#26
JOURNAL ARTICLE
Lei Yang, Liqiang Wei, Xin Li, Jia Cong, Jin Ye, Na Yao, Jing Yang, Liang Wang, Jingwen Wang
OBJECTIVE: To assess the impact of different treatment strategies and risk factors on the prognosis of patients with extranodal NK/T-cell lymphoma, nasal type (ENKTL) in a single medical center. METHODS AND ANALYSIS: The clinical features of 266 patients with ENKTL were retrospectively analyzed, among whom those in stages I and II received sandwich therapy, while those in stages III and IV underwent chemotherapy plus autologous hematopoietic stem cell transplantation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38634052/cytoreductive-surgery-combined-with-hyperthermic-intraperitoneal-chemotherapy-and-intraoperative-radiation-therapy-in-the-management-of-gallbladder-cancer-a-case-report
#27
Marwan Alaswad, Abdullah Al Otry, Ziad Alhosainy, Fadwa Elkordy, Belal Nedal Sabbah, Tarek Ziad Arabi, Humzah Abdulkader, Obaida Fadi Ghanayem, Ayman Zaki Azzam, Tarek Amin
Gallbladder cancer (GBC) is a rare and highly aggressive malignancy, often characterized by nonspecific clinical presentations and late diagnosis, which contribute to its poor prognosis. It is commonly detected at advanced stages, leading to low survival rates. Surgical resection is the primary treatment, with the extent of surgery depending on the T stage of the cancer. In advanced cases, surgery is only considered if it can potentially be curative. Despite various treatment approaches for advanced GBC, survival outcomes remain poor...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38633941/robotic-resection-in-succinate-dehydrogenase-subunit-b-sdhb-mutated-hereditary-paraganglioma-a-case-report-of-two-patients-and-a-literature-review
#28
Ekaterina Baron, Chih Ching Wu, Kanchan Gupta, Jessica A Wernberg, Michael T Sheehan, Rohit Sharma
Autosomal dominant hereditary paraganglioma-pheochromocytoma syndrome (HPPS) is a rare genetic disorder characterized by neuroendocrine tumor development associated with pathogenic variants in succinate dehydrogenase (SDH) enzyme complex genes. Particularly, HPPS linked to SDHB mutation poses a significant clinical challenge due to its association with aggressive tumor features and a high risk of malignancy. Our report underscores the diversity in the presentation of patients with SDHB-mutated paraganglioma and the feasibility of managing it with a minimally invasive surgical approach...
March 2024: Curēus
https://read.qxmd.com/read/38633805/evaluating-large-language-models-for-drafting-emergency-department-discharge-summaries
#29
Christopher Y K Williams, Jaskaran Bains, Tianyu Tang, Kishan Patel, Alexa N Lucas, Fiona Chen, Brenda Y Miao, Atul J Butte, Aaron E Kornblith
IMPORTANCE: Large language models (LLMs) possess a range of capabilities which may be applied to the clinical domain, including text summarization. As ambient artificial intelligence scribes and other LLM-based tools begin to be deployed within healthcare settings, rigorous evaluations of the accuracy of these technologies are urgently needed. OBJECTIVE: To investigate the performance of GPT-4 and GPT-3.5-turbo in generating Emergency Department (ED) discharge summaries and evaluate the prevalence and type of errors across each section of the discharge summary...
April 4, 2024: medRxiv
https://read.qxmd.com/read/38633795/dysregulation-of-lncrna-malat1-contributes-to-lung-cancer-in-african-americans-by-modulating-the-tumor-immune-microenvironment
#30
Jin Li, Pushpa Dhilipkannah, Van K Holden, Ashutosh Sachdeva, Nevins W Todd, Feng Jiang
African American (AA) populations present with notably higher incidence and mortality rates from lung cancer in comparison to other racial groups. Here, we elucidate the contribution of long non-coding RNAs (lncRNAs) in the racial disparities and their potential clinical applications in both diagnosis and therapeutic strategies. AA patients had elevated plasma levels of MALAT1 and PVT1 compared with cancer-free smokers. Incorporating these lncRNAs as plasma biomarkers, along with smoking history, achieved 81% accuracy in diagnosis of lung cancer in AA patients...
April 6, 2024: medRxiv
https://read.qxmd.com/read/38633793/factors-influencing-survival-outcomes-in-patients-with-stroke-in-zimbabwe-a-12-month-longitudinal-study
#31
Farayi Kaseke, Lovemore Gwanzura, Cuthbert Musarurwa, Elizabeth Gori, Tawanda Nyengerai, Timothy Kaseke, Aimee Stewart
BACKGROUND: In this longitudinal study, we aimed to determine factors influencing survival outcomes among patients with stroke over a 12-month period. The investigation sought to uncover influential determinants to enhance the precision of prognostic assessments and inform targeted interventions for individuals affected by strokes. METHODS: Employing a longitudinal study design, participants were observed for 12 months from baseline, censoring survivors at the endpoint...
April 3, 2024: medRxiv
https://read.qxmd.com/read/38633747/derangements-of-immunological-proteins-in-hiv-associated-diffuse-large-b-cell-lymphoma-the-frequency-and-prognostic-impact
#32
JOURNAL ARTICLE
Jenifer Vaughan, Moosa Patel, Melinda Suchard, Maemu Gededzha, Heena Ranchod, Wayne Howard, Tracy Snyman, Tracey Wiggill
INTRODUCTION: Diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy of B-cells frequently encountered among people living with HIV. Immunological abnormalities are common in immunocompetent individuals with DLBCL, and are often associated with poorer outcomes. Currently, data on derangements of immunological proteins, such as cytokines and acute phase reactants, and their impact on outcomes in HIV-associated DLBCL (HIV-DLBCL) is lacking. This study assessed the levels and prognostic relevance of interleukin (IL)-6, IL-10 and Transforming Growth Factor Beta (TGFβ), the acute phase proteins C-reactive protein (CRP) and ferritin; serum free light chains (SFLC) (elevation of which reflects a prolonged pro-inflammatory state); and the activity of the immunosuppressive enzyme Indoleamine 2,3-dioxygenase (IDO)in South African patients with DLBCL...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38633667/research-progress-on-optimization-of-in-vitro-isolation-cultivation-and-preservation-methods-of-dental-pulp-stem-cells-for-clinical-application
#33
REVIEW
Xinxin Wang, Fenyao Li, Shuting Wu, Wenbo Xing, Jiao Fu, Ruoxuan Wang, Yan He
Due to high proliferative capacity, multipotent differentiation, immunomodulatory abilities, and lack of ethical concerns, dental pulp stem cells (DPSCs) are promising candidates for clinical application. Currently, clinical research on DPSCs is in its early stages. The reason for the failure to obtain clinically effective results may be problems with the production process of DPSCs. Due to the different preparation methods and reagent formulations of DPSCs, cell characteristics may be affected and lead to inconsistent experimental results...
2024: Frontiers in Bioengineering and Biotechnology
https://read.qxmd.com/read/38633646/functional-analysis-of-postural-spinal-and-pelvic-parameters-using-static-and-dynamic-spinometry
#34
JOURNAL ARTICLE
Tobias Bode, Schima Zoroofchi, Eik Vettorazzi, Jan-Niklas Droste, Götz H Welsch, René Schwesig, Robert Percy Marshall
BACKGROUND: Spinometry is a radiation-free method to three-dimensional spine imaging that provides additional information about the functional gait patterns related to the pelvis and lower extremities. This radiation-free technology uses the surface topography of the trunk to analyze surface asymmetry and identify bony landmarks, thereby aiding the assessment of spinal deformity and supporting long-term treatment regimes. Especially reliable dynamic spinometric data for spine and pelvis are necessary to evaluate the management of non-specific back pain...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38633595/protein-corona-composition-of-gold-nanocatalysts
#35
JOURNAL ARTICLE
Ali Akbar Ashkarran, Soheyl Tadjiki, Zijin Lin, Kylie Hilsen, Noor Ghazali, Sarah Krikor, Shahriar Sharifi, Meisam Asgari, Michael Hotchkin, Adam Dorfman, Karen S Ho, Morteza Mahmoudi
The interaction between nanoparticles (NPs) and biological environments is profoundly influenced by a stable, strongly adsorbed "hard" protein corona. This corona significantly determines the NPs' pharmacokinetics and biological destiny. Our study delves into the mechanisms by which colloidal Au nanocrystals that are synthesized electrochemically without surface-capping organic ligands, known as CNM-Au8, traverse the blood-brain barrier (BBB) and target human brain tissue for treating neurodegenerative disorders...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38633575/marginal-zone-lymphoma-international-prognostic-index-a-unifying-prognostic-index-for-marginal-zone-lymphomas-requiring-systemic-treatment
#36
JOURNAL ARTICLE
Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, Michele Merli, Nicole Fabbri, Maria Elena Nizzoli, Matthew J Maurer, Vittoria Tarantino, Simone Ferrero, Sara Rattotti, Annalisa Talami, Roberta Murru, Arushi Khurana, Raphael Mwangi, Marina Deodato, Emanuele Cencini, Francesca Re, Carlo Visco, Andrew L Feldman, Brian K Link, Marcia Torresan Delamain, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés J M Ferreri, Caterina Cecilia Stelitano, Elsa Pennese, Thomas M Habermann, Luigi Marcheselli, Sunwoo Han, Isildinha M Reis, Marco Paulli, Izidore S Lossos, James R Cerhan, Stefano Luminari
BACKGROUND: Marginal zone lymphomas (MZL), comprised of three unique but related subtypes, lack a unifying prognostic score applicable to all the patients in need for systemic chemotherapy and/or immunotherapy. METHODS: Patients from the prospective NF10 study (NCT02904577) with newly diagnosed MZL and receiving frontline systemic therapy at diagnosis or after observation were used to train a prognostic model. The primary endpoint was progression-free survival (PFS) from start of treatment...
June 2024: EClinicalMedicine
https://read.qxmd.com/read/38633125/poor-outcomes-for-trial-ineligible-patients-receiving-polatuzumab-for-relapsed-refractory-diffuse-large-b-cell-lymphoma-in-routine-care-an-australian-lymphoma-and-related-diseases-registry-project
#37
JOURNAL ARTICLE
Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes
Polatuzumab vedotin (Pola) is an approved therapy in combination with rituximab and bendamustine for relapsed or refractory diffuse large B-cell lymphoma (RR-DLBCL) based on positive results of the landmark phase II randomised G029365 trial. However, trial results for many approved novel therapies in RR-DLBCL have not been replicated in routine care cohorts, as RR-DLBCL patient populations are heterogeneous and trial eligibility is increasingly restrictive. We evaluated outcomes from pola ± bendamustine and rituximab in patients with RR-DLBCL enrolled in a compassionate access program with no alternative treatment options identified via the Australasian Lymphoma and Related Diseases Registry according to their eligibility for the original phase II published study...
April 2024: EJHaem
https://read.qxmd.com/read/38633122/nationwide-implementation-of-lenalidomide-maintenance-in-multiple-myeloma-a-retrospective-real-world-study
#38
JOURNAL ARTICLE
Mads Harsløf, Iman Chanchiri, Trine Silkjær, Ulf Christian Frølund, Elena Manuela Teodorescu, Kristina Buchardi Nielsen, Per Ishøy Nielsen, Per Trøllund Pedersen, Katrine Fladeland Iversen, Thomas Lund, Kirsten Grønbæk, Sigrun Thorsteinsdottir, Annette Vangsted, Agoston Gyula Szabo
Lenalidomide maintenance (LM) has shown benefit in progression-free survival (PFS) and overall survival (OS) in clinical trials. LM is the recommended standard of care in patients with newly diagnosed multiple myeloma (MM) after high-dose melphalan and autologous stem cell transplantation (HDM-ASCT). In Denmark, LM has been approved and publicly funded for all patients treated with HDM-ASCT since June 2019. Patients with newly diagnosed MM treated with their first HDM-ASCT between June 2019 and March 2022 were included and followed until data cut-off in June 2023...
April 2024: EJHaem
https://read.qxmd.com/read/38633087/siamese-deep-learning-video-flow-cytometry-for-automatic-and-label-free-clinical-cervical-cancer-cell-analysis
#39
JOURNAL ARTICLE
Chao Liu, Zeng Yuan, Qiao Liu, Kun Song, Beihua Kong, Xuantao Su
Automatic and label-free screening methods may help to reduce cervical cancer mortality rates, especially in developing regions. The latest advances of deep learning in the biomedical optics field provide a more automatic approach to solving clinical dilemmas. However, existing deep learning methods face challenges, such as the requirement of manually annotated training sets for clinical sample analysis. Here, we develop Siamese deep learning video flow cytometry for the analysis of clinical cervical cancer cell samples in a smear-free manner...
April 1, 2024: Biomedical Optics Express
https://read.qxmd.com/read/38632994/high-indoleamine-2-3-dioxygenase-transcript-levels-predict-better-outcome-after-front-line-cancer-immunotherapy
#40
JOURNAL ARTICLE
Yu Fujiwara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Jeffrey M Conroy, Paul DePietro, Sarabjot Pabla, Scott M Lippman, Razelle Kurzrock
Indoleamine 2,3-dioxygenase 1 (IDO1), which catabolizes tryptophan, is a potential target to unlock the immunosuppressive tumor microenvironment. Correlations between IDO1 and immune checkpoint inhibitor (ICI) efficacy remain unclear. Herein, we investigated IDO1 transcript expression across cancers and clinical outcome correlations. High IDO1 transcripts were more frequent in uterine (54.2%) and ovarian cancer (37.2%) but varied between and within malignancies. High IDO1 RNA expression was associated with high expression of PD-L1 (immune checkpoint ligand), CXCL10 (an effector T cell recruitment chemokine), and STAT1 (a component of the JAK-STAT pathway) (all multivariable p  < 0...
April 19, 2024: IScience
keyword
keyword
3402
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.